Navigation Links
Clemson bioengineer wins prestigious Early Career Award
Date:8/15/2008

CLEMSON Ning Zhang, assistant professor of bioengineering at Clemson University and the CU-MUSC Bioengineering Program, has received the prestigious 2008 Early Career Translational Research Award from the Wallace H. Coulter Foundation.

The foundation judged Zhang's research on an injectable hydrogel-based system for the treatment of stroke to be a highly promising technology that can progress towards commercial development and clinical practice. Zhang proposed the injectable hydrogel system to assist stem cell therapy for stroke treatment.

"This award exemplifies the strong leadership of Dr. Zhang in translational biomaterials research based on outstanding basic science," said Martine LaBerge, chair of Clemson's bioengineering department. "Our goal as bioengineers is to get potential life-saving treatments such as this from the research lab to the patient in an expedient manner."

The Early Career Translational Research Awards support biomedical engineering research that is translational in nature and encourage and assist eligible biomedical engineering investigators as they establish themselves in academic research careers with two years of funding.

Zhang's research on neurobioengineering has also been recognized by the 2007 Department of Defense Post-Traumatic Stress Disorder/Traumatic Brain Injury Research Program of the Office of the Congressionally Directed Medical Research Programs (CDMRP) with a Concept Award on "Brain Tissue Regeneration After Traumatic Brain Injury."

The Wallace H. Coulter Foundation is a private, nonprofit foundation in Miami dedicated to improving human healthcare by supporting translational research in biomedical engineering. Recipients of the Early Career Translational Research Awards are full-time, tenure-track faculty members with a primary appointment in biomedical engineering. They have received their doctoral degree no more than six years prior to their application, and they held a
'/>"/>

Contact: Martine LaBerge
laberge@clemson.edu
864-656-5557
Clemson University
Source:Eurekalert

Page: 1 2

Related biology news :

1. NIH recognizes Clemson nanotechnology for molecule tracking
2. Clemson physicist addresses international forum on thermoelectric energy
3. Clemson scientists shed light on molecules in living cells
4. Clemson chemists discover new way antioxidants fight debilitating diseases
5. UC Riverside bioengineer receives high honor from chemical engineers
6. Brown hosts regional bioengineering conference
7. From stem cells to organs: The bioengineering challenge
8. UCSD bioengineering grad student wins leadership award
9. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
10. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
11. Springer editor Toshisada Nishida winner of 2 prestigious primatology awards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ration is now open for the Society of Intervention...gy (IO) Therapies" Webinar, which will provide the...treatment of liver tumors, kidney tumor ablation a...tion of physicians, scientists and allied health p...through pioneering advances in image-guided therap...
(Date:11/6/2009)... generally live in harmony with their arboreal hos...ut of space in their trees of choice, the ants can...earch, published in the November issue of the Ame...nts bore into live trees, and it reopens a centuri... plants. , Ants and certain species of plants an...
(Date:11/6/2009)...mber 06, 2009) The Monell Center and the Chinese ...ing International Meeting on Taste and Smell Resea... CAS, the meeting will be the first international ... Alan Leshner, Chief Executive Officer, American ...cutive Publisher of Science magazine, will open th...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Ants are friendly to some trees, but not others 2Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 1Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 2Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 3Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 4Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 5Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 6Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 7Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 8XLHealth Appoints New Vice President of Contracting and Provider Relations 50536 1XLHealth Appoints New Vice President of Contracting and Provider Relations 50536 2Siblings target of intervention program 50533 1
...Swedish amateur boxers suggests that they have hig...inal fluid in the days following a bout, indicatin... brain function, according to a report in the Sept...AMA/Archives journals. , About 20 percent of profe...ury, according to background information in the ar...
... researchers have devised a way to use a brief bur...particles from a tiny gold launch pad. The techniq... of medicine on command from a chip implanted in t... reactions that require the controlled release of ...echnique was described Sept. 10 in a presentation ...
...s found that close to half of 154 smokers who had ...p a cigarette again within 12 months of their pot...rd were smoking at the one year mark. Sixty percen...hin two months of surgery. , The study, led by res...ne and published in the December issue of Cancer E...
Other Biology News:Amateur boxing linked to brain cell injury 2Electric jolt triggers release of biomolecules, nanoparticles 2Successful lung cancer surgery not enough to break nicotine dependence in many smokers 2Successful lung cancer surgery not enough to break nicotine dependence in many smokers 3
(Date:11/9/2009)... BEIJING, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Yo...e or "the Company") a leading manufacturer, develo... animal nutrient products in the,People,s Republic...uct a,conference call at 10:00 a.m. Eastern Time (...009 to discuss results for the quarter ended Septe...
(Date:11/9/2009)... DIEGO, Nov. 9 NexBio, Inc. announ...l American College of Allergy, Asthma, and Immunol...led "DAS181 (Fludase®), a Sialidase, Decrease...ry Effects in Animal Models of Asthma". ,, DAS1...pectrum host-targeting drug candidate being studie...
(Date:11/9/2009)... LONDON, November 9 Following the ...S Food and Drug Administration (FDA), privately,ow...//www.davalinternational.com ) has been informed t...(R) has been awarded an Orphan-Drug,designation fo...ALS). , ALS, also known as Lou Gehrig,s d...
(Date:11/6/2009)...ONTO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Bio...it has re-filed the Form 52-109F1 Certification of...tive Officer and James Long, the Chief Financial O...y 12, 2009 in connection with the annual audited f...0, 2008. ,, The Company initially filed the ann...
Breaking Biology Technology:Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3
...s, CEO of ReBuilder,Medical Technologies, Inc. (Pi... ),will be featured in an exclusive interview with...th. The interview will be posted on http://www.wa...terview will cover topics including ReBuilder Medi...initiatives, competitive,edge, recent news, and mi...
...Call/ - Quest PharmaTech Inc. (TSX,Venture Exchang...ement with,a multinational technology development ...develop oncology products based on its SonoLight T... Pharma Tech Inc. ("Quest" or the,"Company") has a...000,000,will be paid within the next twelve months...
...phagenics,Limited ("Phosphagenics") (ASX: POH, AIM...lts of its Phase 1 clinical trial that showed its,...elief drug oxycodone,through the skin without caus...results support Phosphagenics, aims to be the firs...codone patch for the management of,chronic pain., ...
Other Biology Technology:WallSt.net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies 2Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology 2Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 2Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 3
Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Mouse Anti-Mouse Ly 6C.2(Ly 28.2) Monoclonal Antibody, Unconjugated, Clone 5075-3.6 from CEDARLANE Laboratories Limited
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Biology Products: